COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Anti-viral Effect of PC786 on RSV Infection on HSCT Recipients (TreatRSV1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03715023
Recruitment Status : Terminated (Practical issues that could not be resolved resulting in recruitment difficulties at sites.)
First Posted : October 22, 2018
Last Update Posted : June 12, 2019
Information provided by (Responsible Party):
Pulmocide Ltd

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : February 19, 2019
Actual Study Completion Date : May 1, 2019